01
GLP-1 agonist
Compounded Semaglutide
From $353 / month
Weekly therapy with physician review, dose guidance, refill coordination, and monitoring tied to response and tolerance.
01
Metabolic Care
GLP-1 care with the guardrails patients pay for.
Semaglutide, tirzepatide, and related options are reviewed with your labs, appetite pattern, side effects, body-composition goals, and long-term maintenance in mind.
Plate 01 · Metabolic care
Endpoint
Lean mass preserved. Visceral fat reduced.
02 · Treatment Options
Medication is only part of the plan.
Therapeutic cost, dose changes, and monitoring are reviewed together. Labs help determine whether the next step is appropriate.
02
GLP-1 / GIP co-agonist
Compounded Tirzepatide
From $453 / month
A dual-incretin option for patients whose metabolic history may need a broader approach. Labs and follow-up are part of the plan.
03
Emerging review
Retatrutide Review
By consultation
Discussed only in select cases. Eligibility depends on current evidence, history, response, and risk profile.
No charge until your initial consultation is confirmed.
03 — What is included
- Private physician review before medication is recommended.
- Qualified pharmacy coordination when compounded medication is appropriate.
- Dose, refill, and side-effect support so treatment does not feel unmanaged.
- Metabolic labs, including HOMA-IR, lipids, and hepatic markers, when indicated.
04 — Clinical Standards
- Therapies are prescribed only when medically appropriate after physician review.
- Compounded formulations are patient-specific and differ from FDA-approved brand products.
- Dose timing is driven by labs, tolerance, weight trajectory, and symptom response.
- Discontinuation is a clinical option when biomarkers warrant it.
05 · The point
The scale is one data point. The chart explains what to do with it.